« Previous
Next »
Heart Rhythm
Volume 6, Issue 3,
Supplement
, Pages
S36-S44
, March 2009
Evidence regarding clinical use of microvolt T-wave alternans
To access this article, please choose from the options below
Dr. Hohnloser has research grant, consultancy, and speaker's bureau associations with St. Jude Medical and Sanofi Aventis. The MTWA technology was developed in Dr. Cohen's laboratory at the Massachusetts Institute of Technology (MIT). MIT licensed the technology to Cambridge Heart, Inc. Dr. Cohen has a financial involvement with Cambridge Heart as a consequence of the original licensure of the technology and his ongoing service as a consultant, director, and speaker's bureau member. Dr. Cohen has been a consultant to Medtronic, Inc. Dr Takanori Ikeda has no conflict of interest.
PII: S1547-5271(08)00978-8
doi: 10.1016/j.hrthm.2008.10.011
© 2009 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Heart Rhythm
Volume 6, Issue 3,
Supplement
, Pages
S36-S44
, March 2009
